Western Canadian Neuromuscular Conference Accepting Scientific Abstracts for Research Symposium
The 5th Western Canadian Neuromuscular Conference is being held in Calgary on September 27 – 29, 2024. The conference is designed for general neurologists, neuromuscular specialists, physical medicine and rehabilitation specialists, trainee physicians with interest in Neuromuscular Medicine and allied health members from the neuromuscular community.
The WCNMC provides updates on recent advances in the diagnosis and management of common nerve, muscle and motor neuron diseases, witha blend of short didactic presentations, interactive discussions, plenary sessions and question answer, and a research symposium.
The research symposium on Sunday September 29 will focus on focus on trainee-led basic science, translational, clinical, and qualitative research related to neuromuscular disease. We encourage anyone attending the event to submit an abstract for consideration!
Abstracts for the research symposium will be accepted until September 6, 2024. Please visit the WCNMC website for instructions on how to submit your abstract.
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.